Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The archive
Page 44 of 170 of this archive, newest first.
STEP 2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Portugal pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
The reviewer, the approver, and why regulated documents carry two names
A manufacturer’s certificate is a self-declaration. An accredited laboratory’s report is a third-party measurement. The trade prints both under one heading.
Percentage of loss, absolute kilograms, and the sleight of hand between them
What was pre-specified, what was exploratory, and what was calculated afterwards by people who did not run the trial.
From the floor in Tianjin: 20 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
The 8-day notice: how a compounding wind-down works in Spain
The document is four pages. Three of them are about dates.
From the floor in Zhuhai: 21 posters, one theme
Reported from the sessions, and from the two hours afterwards.
HbA1c and its lag: what a result three months old is telling you
HbA1c integrates roughly three months of glycaemia with the most recent weeks weighted most heavily. Almost every misreading of it is a misreading of that weighting.
Accreditation, scope, and the question nobody asks Medutest
A manufacturer’s certificate is a self-declaration. An accredited laboratory’s report is a third-party measurement. The trade prints both under one heading.
What the trials monitored, and what that implies about routine practice
The argument for a baseline panel is that it makes every subsequent result interpretable. The argument against frequent monitoring is that noise accumulates faster than…
Australia pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
Changsha export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Independent analysis puts a FGP survodutide lot at 95.6%, against 92.9% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Delayed emptying explains some of this, and not all of it
The receptor populations that produce satiety and the ones that produce nausea overlap substantially. That is why the ceiling of this drug class is where it is, and it is…
The 26-day notice: how a compounding wind-down works in Poland
The document is four pages. Three of them are about dates.
What changed at HJ in November, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
PeptideMeter result on a Tianjin retatrutide lot lands 3.7 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
The dose that got you here and the dose that keeps you here
What the labels permit, what clinicians do, and the size of the gap between them.
Why "muscle-sparing" is a marketing term and not a measurement
Grading six widely repeated claims against the studies actually behind them.
Why VendorInvestigate may run electrospray where another laboratory runs MALDI
The two ionisation techniques in general use produce different charge distributions, different adducts and different failure modes. Certificates almost never say which was…
From the floor in Wuxi: 11 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The United Arab Emirates health authority warns on falsified liraglutide pens
Reported from the analysis, not from a warning notice.
Hong Kong export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
From the floor in Suzhou: 14 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Load, not cardio: the distinction the general advice keeps losing
Mass and function are different endpoints and training affects them differently. Most coverage treats them as one.
Why people actually stop, in the order they actually stop
A supply interruption is a discontinuation with no notice, no taper and no plan. That is a distinct clinical situation.